Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT
Clinical trial NCT06664996 · RECRUITING
Trial details
- NCT number
- NCT06664996
- Sponsor
- West China Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-15
- Primary completion
- 2025-10-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.